The Cambridge UK Biopharmaceutical R&D Service Platform, led by Agile Biomedical Consultants and presented by Dr Hussein Al-Ali at the Dinghu High-Level Talent Innovation and Entrepreneurship Project overseas session on 28 November 2025, has passed review and been approved as a pioneer talent initiative.
The approval secures more than £1 million in funding and additional subsidies to establish an operational base in Linping District, Hangzhou. It is part of Hangzhou's strategy of attracting international projects and talent into the local innovation ecosystem.
Our team will begin a two-phase implementation plan in 2026, building biopharmaceutical R&D services in partnership with local stakeholders in Hangzhou.